Skip to Main Content

News Center

One Day in the ICU without Care from a Pharmacist Increases Death by 20%

Patient mortality also linked to pharmacist workload, new study involving UMSOP faculty finds.

By Emily Bleiweis
November 17, 2026

Patients in intensive care units (ICU) who don’t receive care from a pharmacist for even one day of their stay are 20 percent more likely to die, according to new research involving the University of Maryland School of Pharmacy (UMSOP).

The study, which was led by the University of Georgia (UGA) with Mojdeh Heavner, PharmD, BCCCP, FCCM, FCCP, professor of practice, sciences, and health outcomes research at UMSOP as a member of the study’s leadership team, also found ICU patients were 10 percent more likely to die when pharmacists were responsible for more than 15 patients. For every one patient increase in a pharmacist’s workload, the odds of a patient dying increased by 1 percent.

“I’ve seen firsthand the benefits of having and the consequences of not having dedicated critical care pharmacists at the bedside,” said Heavner, who is also UMSOP’s assistant dean for experiential learning and coordinator of the University of Maryland’s pharmacotherapy residency program.

“These findings reinforce that pharmacist coverage in the ICU is not simply a staffing decision. It’s a patient safety and survival issue,” she added.

The researchers analyzed data from 213 pharmacists across 64 hospitals in the United States. The pharmacists provided information on their workload and every patient they cared for each day for 100 consecutive days, resulting in data from more than 28,000 patients. The researchers then compiled information on those patients’ severity of illness, health outcomes, and more.

“Critically ill patients experience an average of 1.7 medical errors per day, and nearly 80 percent of serious errors are caused by medications,” said Susan Smith, PharmD, BCCCP, FCCM, FCCP, lead author of the study and an associate professor of clinical and administrative pharmacy in UGA’s College of Pharmacy. Smith also practices critical care pharmacy in a Georgia ICU and is an affiliate associate professor at UMSOP. “The comprehensive medication management provided by pharmacists is essential for ensuring medication safety.”

“Previous research has shown that having pharmacists present in ICUs is good and that it improves outcomes,” Smith said. “But this is the first publication to show that we need pharmacists in the ICU every day, seven days a week, 365 days a year.”

Pharmacists guard against adverse drug events

Critical care pharmacists are an integral part of the medical team in hospital ICUs. They review medications for potential drug interactions, optimize medication dosing, and determine if a different medication would be a better fit.

Critical care pharmacists act as a key safeguard against adverse drug events, which kill an estimated 250,000 hospital patients each year.

“These findings could directly influence ICU care by reinforcing the importance of having critical care pharmacists involved in medication management every day of a patient’s ICU stay,” said Andrea Sikora, PharmD, MSCR, FCCP, FCCM, a senior author on the study and associate professor of biomedical informatics at the University of Colorado Anschutz School of Medicine.  “The study also highlights the importance of evidence-based team design and the power of large-scale collaboration across institutions.”

Hospital staffing, budgets may pose obstacle to patient care

Most hospitals have critical care pharmacists in their ICU, but an average of one-third don’t, according to recent studies. Those with pharmacists are often limited to pharmacist presence on weekdays and day shifts.

As hospital budgets shrink, having a critical care pharmacist on call 24/7 isn’t always a priority. Adding pharmacists to the team would likely save money in the long term through shorter patient stays and less reliance on costly life-sustaining measures, the researchers said.

“We found a clear association between pharmacist workload and patient mortality. We hope these data will help hospital leaders advocate for the resources needed to ensure patients have access to critical care pharmacy expertise every day of their ICU stay,” Heavner said.

Published by CHEST Journal, the study was co-authored by Kristine Parbuoni, PharmD, BCPPS, associate professor in P-SHOR at UMSOP, associate dean for PharmD students, and director of postgraduate training. Several previous UMSOP pharmacy residents, including Alyssa Castillo, PharmD, and Leslie Banuelos, PharmD, as well as former student pharmacists Alexis Glenn, PharmD, Christine Rojas, PharmD, and Maya Smith, PharmD, were also part of the study team. Additional co-authors included researchers from the University of Maryland Medical Center and the University of Maryland Upper Chesapeake Medical Center.

UMSOP’s Pharmaceutical Research Computing provided programming assistance on primary datasets and created the analytic files that were used for the study.